New program aims to cut seizures and boost quality of life for epilepsy patients in uganda
NCT ID NCT06139198
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests a 12-week self-management program (SMART-U) for adults with epilepsy in Uganda. The program includes group sessions and phone follow-up to help people manage their condition. Researchers will compare seizure frequency and quality of life between those in the program and those receiving usual care, with 190 participants total.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Self-management behavioral program (SMART-U)
- What this could lead to
- If successful, this program could provide a low-cost way for people with epilepsy in Uganda to better control seizures and improve their daily lives.
- What could go wrong
- This is a relatively small, early-stage trial focused on behavioral change, not a new drug. Results may not apply to other settings, and the program requires significant time commitment from participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mulago National Referral and Teaching Hospital
Kampala, Uganda
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can community hospitals in zambia master severe disease care?
- Can mindfulness rewire the mind to lift depression in epilepsy?
- A break from seizure pills: could less medication mean better living?
- Can invisible electric fields quiet the Brain's seizure signals?
- Can a new drug tame severe childhood epilepsy?